Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Future Healthcare Journal

  • FHJ Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About FHJ
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Future Healthcare Journal

futurehosp Logo
  • FHJ Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About FHJ
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Use of community-based subcutaneous furosemide in advanced heart failure: experience of a new service in the north-east of England

Andrew Brown, Judith Robson, Leonie Armstrong, Iain Matthews, Craig Runnett and Honey Thomas
Download PDF
DOI: https://doi.org/10.7861/futurehosp.6-1-s19
Future Healthc J March 2019
Andrew Brown
Northumbria Healthcare NHS Trust, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith Robson
Northumbria Healthcare NHS Trust, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonie Armstrong
Northumbria Healthcare NHS Trust, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iain Matthews
Northumbria Healthcare NHS Trust, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig Runnett
Northumbria Healthcare NHS Trust, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Honey Thomas
Northumbria Healthcare NHS Trust, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Aims

Evaluation of a community-based subcutaneous furosemide service for the treatment of advanced heart failure.

Methods

We have initiated a community-based subcutaneous furosemide service for the treatment of advanced heart failure. In patients with end-stage heart failure, there is some evidence which suggests that furosemide can be given subcutaneously to relieve symptoms and avoid hospital admission. Our treatment guidelines were developed in collaboration with cardiologists, specialist nurses, palliative care and community nursing teams. All patients have a comprehensive emergency healthcare plan (EHCP) involving the heart failure team and delivery of the service is facilitated by community heart failure and district nurses in patients’ homes. Our service aims to increase patient choice, reduce avoidable hospital admissions, facilitate early discharge and improve quality of life. We collected background and episode-related data for all patients with advanced heart failure that received subcutaneous furosemide.

Results

Subcutaneous furosemide was used in 19 treatment episodes in 16 patients. The majority had left ventricular systolic dysfunction (LVSD) (87%, 14/16). The median (interquartile range (IQR)) length of treatment was 10 (5–19) days. Median weight loss of 5 (2–7.5) kg was recorded over the course of treatment. Eleven patients’ EHCPs were initially drawn up in secondary care and five in the community.

50% (8/16) of patients died during treatment, 6/8 died at home and 2/8 died at our specialist palliative care unit. Both patients were admitted as a result of difficulty managing the syringe driver at home. Of the treatment episodes which the patient survived, 18% (2/11) of patient episodes resulted in readmission. This was for assistance with syringe driver management and assessment following a fall at home.

For those patients who were alive on completion of initial subcutaneous furosemide course (n=8) there were 10 admissions to hospital over a median survival period of 6 months. In the preceding 6 months there were 21 admissions in the same patient group.

Conclusion

Our data suggests that subcutaneous furosemide can be successfully delivered in the community. In addition to palliation in the final days of life, community subcutaneous furosemide can be an effective treatment leading to significant weight loss and improved symptoms and survival for several months. This approach allows management of worsening symptoms in the community and we have shown a reduction in hospital admissions in a group at high risk of hospital readmissions.

Conflict of interest statement

The authors have no conflict of interest to declare.

  • © Royal College of Physicians 2019. All rights reserved.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Use of community-based subcutaneous furosemide in advanced heart failure: experience of a new service in the north-east of England
Andrew Brown, Judith Robson, Leonie Armstrong, Iain Matthews, Craig Runnett, Honey Thomas
Future Healthc J Mar 2019, 6 (Suppl 1) 19; DOI: 10.7861/futurehosp.6-1-s19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Use of community-based subcutaneous furosemide in advanced heart failure: experience of a new service in the north-east of England
Andrew Brown, Judith Robson, Leonie Armstrong, Iain Matthews, Craig Runnett, Honey Thomas
Future Healthc J Mar 2019, 6 (Suppl 1) 19; DOI: 10.7861/futurehosp.6-1-s19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Aims
    • Methods
    • Results
    • Conclusion
    • Conflict of interest statement
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Adherence to therapy in chronic inflammatory rheumatic diseases: the older the better
  • A review in general practice: the appropriate prescription of PPIs with those taking aspirin over the age of 70
  • A rare case of ascites
Show more Clinical

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home

Other Services

  • Advertising
futurehosp Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians